US Stock MarketDetailed Quotes
PKBO Peak Bio
- 0.005200
- 0.0000000.00%
15min DelayTrading Apr 18 16:00 ET
116.46KMarket Cap-9P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.005200Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)22.40MShares1.00000052wk High-0.01P/B56.36KFloat Cap0.00200052wk Low--Dividend TTM10.84MShs Float14.999700Historical High--Div YieldTTM0.00%Amplitude0.002000Historical Low--Avg Price1Lot Size
About Peak Bio Company
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease. The company is headquartered in Pleasanton, CA.
Company Profile
SymbolPKBO
Company NamePeak Bio
Listing DateMar 15, 2021
Founded2016
CEOMr. Stephen LaMond, M.B.A.,Pharm.D.
MarketPink Market
Employees14
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4900 Hopyard Road,Suite 100
CityPleasanton
ProvinceCalifornia
CountryUnited States of America
Zip Code94588
Websitehttps://www.peak-bio.com
Company Executives
- Name
- Position
- Salary
- Stephen LaMond, M.B.A.,Pharm.D.
- Interim Chief Executive Officer, Chief Operating Officer, Secretary and Director
- --
- Timothy M. Cunningham
- Acting Chief Financial Officer
- --
- Satyajit Kumar Mitra
- Executive Director and Head of Oncology
- --
- Dr. Hoyoung Huh,M.D.,PhD
- Director
- --
- Nevan Charles Elam, J.D.
- Lead Independent Director
- --
- James R. Neal, M.B.A.,M.S.
- Independent Director
- --
- David I. Rosenberg
- Independent Director
- --
- Brad Stevens
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg